Abstract:BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can differentiate into hepatocyte-like cells in vivo and vitro and show hepatocyte function such as synthesis and secretion. OBJECTIVE: To induce and differentiate BMSCs into hepatic cells, which are transplanted into homogeneitic rat livers that had fibrous degenerated, and to observe the distribution, differentiation and effects of the hepatocytes on hepatic function. DESIGN, TIME AND SETTING: Randomized controlled animal experiment was performed at the Laboratory of Hospital Affiliated to Luzhou Medical College from June 2007 to March 2008. MATERIALS: A total of 10 clean male Sprague Dawley rats weighing 100 g were selected to culture BMSCs and to be induced and differentiated into hepatocyte-like cells. A total of 75 clean male Sprague Dawley rats weighing 200-250 g were randomly divided into hepatocyte-like cell transplantation group (n=30), model control group (n=30) and normal control group (n=15). Rats in the hepatocyte-like cell transplantation group and model control group intraperitonealy underwent carbon tetrachloride to prepare animal models of hepatic fibrosis. METHODS: Rats in the model control group and normal control group were subjected to serum-free low-glucose DMEM via portal vein infusion. Rats in the hepatocyte-like cell transplantation group received DAPI labelled hepatocyte-like cells. All rats were sacrificed to obtain liver and serum samples at 1, 2, 3 and 4 weeks following transplantation. MAIN OUTCOME MEASURES: Degree of the hepatic fibrosis was evaluated though Masson triple stain. Frozen sections were made to detect transformation of livers which had been transplanted cells with a fluorescence microscope. Serum the parameters of liver function and hepatic fibrosis were detected by the automatic biochemistry analyzer and radio-immunifaction method. RESULTS: Transplanted cells from the blood vessels gradually accessed into the liver, and eventually distributed between the liver cells scattered. But after three weeks of transplantation, fluorescence obviously decayed. At week 2, liver false lobular gradually absorbed or dissipated, and fibrosis significantly milder than the model control group, with collagen staining lighting and distributing in the fiber interval and portal area, and liver cells presented Balloon-like degeneration. At week 4, liver cells arranged in normal. Dot necrosis was occasionally found without fiber interval. No significant differences in the parameters of liver function and hepatic fibrosis were found compared with the normal control group(P > 0.05). CONCLUSION: Induced hepatocyte-like cells could engraft into fibrotic liver after transfusion as early as on the 7th day and localized in collection tube region and liver sinus. Results of biochemistry detection showed that the engrafted hepatocyte-like cells could substitute liver function partly.

G-CSF mobilized PBMCs contribute to the liver function of cirrhotic rats

Hematopoietic stem cells mobilized by granulocyte colony-stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation.

Granulocyte Colony-Stimulating Factor-Mobilized Autologous Bone Marrow Stem Cells Promote the Liver Regeneration of Partial Liver Transplant: an Experiment with Rats

Human CD34+ Cells Mobilized by Granulocyte Colony-Stimulating Factor Ameliorate Radiation-Induced Liver Damage in Mice

Granulocyte Colony-Stimulating Factor Enhances Bone Marrow Mononuclear Cell Homing to the Liver in a Mouse Model of Acute Hepatic Injury

The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis

Hepatocyte Growth Factor Promotes Liver Regeneration Induced by Transfusion of Bone Marrow Mononuclear Cells in a Murine Acute Liver Failure Model

Granulocyte colony-stimulating factor treatment ameliorates liver injury and improves survival in rats with D-galactosamine-induced acute liver failure.

Hematopoietic stem cell mobilization after rat partial orthotopic liver transplantation.

Therapeutic Potential of Menstrual Blood Stem Cells in Treating Acute Liver Failure

The Experimental Study of BMSCs Transplanted into Rat Models of Liver Cirrhosis

A Study on Stem Cell Mobilization after Partial Liver Transplantation in Rats

Controlled Trials in Hepatitis B Virus-Related Decompensate Liver Cirrhosis: Peripheral Blood Monocyte Transplant Versus Granulocyte-Colony-Stimulating Factor Mobilization Therapy

Transplantation of bone marrow-derived hepatocyte-like cells via the portal vein in rat hepatic fibrosis models

G-CSF Enhanced SDF-1 Gradient Between Bone Marrow and Liver Associated with Mobilization of Peripheral Blood CD34+ Cells in Rats with Acute Liver Failure

Effects of Urokinase Type Plasminogen Activator Gene Transfected Bone Marrow-Derived Liver Stem Cells Transplantation on Hepatocyte Regeneration in Liver Fibrosis Rats

Mesenchymal Stem Cells with Enhanced Bcl-2 Expression Promote Liver Recovery in a Rat Model of Hepatic Cirrhosis.

The Study of Mesenchymal Stem Cells and Mononuclear Cells Heterogenic Transplanted to Improve Liver Damage

Repair of liver mediated by adult mouse liver neuro-glia antigen 2-positive progenitor cell transplantation in a mouse model of cirrhosis

Effects of Gene-Transfected Bone Marrow-Derived Liver Stem Cells Transplantation on Liver Fibrosis in Rats

Bone Marrow Mesenchymal Stem Cell Transplantation Via Different Approaches in Treatment of Liver Cirrhosis in Mice